1. Home
  2. ANTX vs PCLA Comparison

ANTX vs PCLA Comparison

Compare ANTX & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANTX
  • PCLA
  • Stock Information
  • Founded
  • ANTX 2017
  • PCLA 2008
  • Country
  • ANTX United States
  • PCLA Japan
  • Employees
  • ANTX N/A
  • PCLA N/A
  • Industry
  • ANTX Biotechnology: Pharmaceutical Preparations
  • PCLA Building Products
  • Sector
  • ANTX Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • ANTX Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • ANTX 33.2M
  • PCLA 71.3M
  • IPO Year
  • ANTX 2022
  • PCLA 2025
  • Fundamental
  • Price
  • ANTX $1.08
  • PCLA $0.73
  • Analyst Decision
  • ANTX Buy
  • PCLA
  • Analyst Count
  • ANTX 2
  • PCLA 0
  • Target Price
  • ANTX $2.00
  • PCLA N/A
  • AVG Volume (30 Days)
  • ANTX 258.4K
  • PCLA 3.7M
  • Earning Date
  • ANTX 08-12-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • ANTX N/A
  • PCLA N/A
  • EPS Growth
  • ANTX N/A
  • PCLA N/A
  • EPS
  • ANTX N/A
  • PCLA N/A
  • Revenue
  • ANTX N/A
  • PCLA $5,475,228.00
  • Revenue This Year
  • ANTX N/A
  • PCLA N/A
  • Revenue Next Year
  • ANTX N/A
  • PCLA N/A
  • P/E Ratio
  • ANTX N/A
  • PCLA N/A
  • Revenue Growth
  • ANTX N/A
  • PCLA 40.19
  • 52 Week Low
  • ANTX $0.87
  • PCLA $0.37
  • 52 Week High
  • ANTX $3.07
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • ANTX 48.42
  • PCLA N/A
  • Support Level
  • ANTX $1.05
  • PCLA N/A
  • Resistance Level
  • ANTX $1.10
  • PCLA N/A
  • Average True Range (ATR)
  • ANTX 0.04
  • PCLA 0.00
  • MACD
  • ANTX 0.00
  • PCLA 0.00
  • Stochastic Oscillator
  • ANTX 50.00
  • PCLA 0.00

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: